On November 16 2022, Andrea Pennati secured associate membership within the UW Carbone Cancer Center in the UW School of Medicine and Public Health. He has been appointed as a member of the UWCCC’s Developmental Therapeutics Program where innovations in …
Month: November 2022
PACT Intern Completes MS in Applied Drug Development – joins manufacturing team
Xingyi Tang completed her Master of Science in the University of Wisconsin-Madison, School of Pharmacy Applied Drug Development program. Ms. Tang chose to complete the internship portion of her requirements in the UW Program for Advanced Cell Therapy. …
Pilot Study of autologous MSCs for Radiation-Induced Xerostomia (Dry Mouth) in Head and Neck Cancer Patients Completed
The UW Program for Advanced Cell Therapy has completed enrollment for the pilot MARSH (Marrow-derived Autologous Stromal cells for the Restauration of Salivary Hypofunction) clinical trial. Six patients with radiation-induced Xerostomia (Dry Mouth) were treated in the …
PACT Adds New Member to the cGMP Manufacturing Team!
The UW Program for Advanced Cell Therapy welcomes Jessica Murphy, BS, MLS (ASCP) as our new Process Development and Manufacturing Scientist. Ms. Murphy comes to us from the Center for Regenerative Medicine; Immune, Progenitor and Cell Therapy (IMPACT) …
UW PACT submits Annual Report to FDA CBER for Viral-Specific Cell therapy IND
The Annual Report for the IND covering a University of Wisconsin (UW) clinical trial evaluating the safety of donor Viral-Specific T cells against CMV (cytomegalovirus) infection was submitted to the FDA CBER this week. This …